Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
Overview
Pharmacology
Authors
Affiliations
Background: Several adipocytokines have been implicated in the pathogenesis non-alcoholic fatty liver disease (NAFLD).
Aim: To assess adipocytokines in NAFLD patients and controls.
Methods: A total of 95 patients (26 non-alcoholic steatohepatitis (NASH), 19 simple steatosis (SS), 38 obese controls and 12 non-obese controls) were included. Fasting serum insulin, glucose, visfatin, resistin, adiponectin, tumour necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8) and IL-6 were determined. Univariate and multivariate analyses were used to compare groups and determine associations.
Results: Serum TNF-alpha and IL-8 were higher in NAFLD patients when compared with both obese and non-obese controls. Analysis involving all patients revealed a significant correlation between serum TNF-alpha and IL-8 (P < 6.319e-08), and between IL-6 and IL-8 (P < 5.271e-15). Homeostatic model assessment scores negatively correlated with adiponectin in NAFLD (P < 0.0032). Serum visfatin was higher in all three obese groups than in non-obese controls (P < 0.02, P < 0.002 and P < 0.008). Visfatin in NASH patients was lower than SS and obese controls. Although TNF-alpha was associated with NAFLD (P < 0.02), it was interdependent on visfatin. In comparison to SS, four factors were independently associated with NASH: age, alanine aminotransferase, IL-8 and adiponectin (P < 0.05). Multivariate analysis indicated that TNF-alpha was the only independent predictor of fibrosis in NASH (P < 0.0004).
Conclusion: These findings support a complex interaction between adipocytokines and the pathogenesis of NAFLD.
Sakaguchi T, Nagahama Y, Hamada N, Singh S, Mikami H, Maeda K Nutrients. 2024; 16(23).
PMID: 39683544 PMC: 11643772. DOI: 10.3390/nu16234151.
Mishra P, Sadananthan S, Yaligar J, Tan K, Chong Y, Gluckman P BMC Med. 2024; 22(1):561.
PMID: 39605006 PMC: 11600899. DOI: 10.1186/s12916-024-03779-0.
Adrenic acid: A promising biomarker and therapeutic target (Review).
Wang Z, Gao H, Ma X, Zhu D, Zhao L, Xiao W Int J Mol Med. 2024; 55(2).
PMID: 39575474 PMC: 11611323. DOI: 10.3892/ijmm.2024.5461.
Motamedi A, Alizadeh S, Osati S, Raeisi T, Homayounfar R Public Health Nutr. 2024; 27(1):e182.
PMID: 39324343 PMC: 11504692. DOI: 10.1017/S1368980024001149.
Jiang Z, Liang X, Hu L, Ran L, She R, Ma C Clin Transl Oncol. 2024; .
PMID: 39276288 DOI: 10.1007/s12094-024-03665-4.